A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
暂无分享,去创建一个
J. Zerwekh | N. Breslau | C. Pak | D. A. Norman | S. Lawoyin
[1] C. Pak,et al. Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation. , 1978, The American journal of medicine.
[2] M. Haussler,et al. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. , 1977, The New England journal of medicine.
[3] M. Haussler,et al. THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.
[4] J. Fischer,et al. Pseudohypoparathyroidism: Disappearance of the resistance to parathyroid extract during treatment with vitamin D , 1975 .
[5] M. Haussler,et al. Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor. , 1974, Biochemistry.
[6] A. Moses,et al. Parathyroid hormone deficiency with Albright's hereditary osteodystrophy. , 1974, The Journal of clinical endocrinology and metabolism.
[7] C. Pak,et al. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. , 1974, The Journal of clinical investigation.
[8] C. M. Clark,et al. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. , 1972, The Journal of clinical investigation.
[9] A. Gilman. A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Fraser,et al. Pseudohypoparathyroidism: responsiveness to parathyroid extract induced by vitamin D2 therapy. , 1970, The Journal of clinical endocrinology and metabolism.
[11] F. Bartter,et al. Studies in pseudohypoparathyroidism. Two new cases with a probable selective deficiency of thyrotropin. , 1969, The American journal of medicine.
[12] H. Rasmussen,et al. The physiological and cellular basis of metabolic bone disease , 1973 .